Trio-Tech director granted 70,000 stock options
Trio-Tech International director Jason T. Adelman was granted stock options covering 70,000 shares of common stock.
Rhea-AI Filing Summary
Trio-Tech International director Jason T. Adelman was granted stock options covering 70,000 shares of common stock. The options have an exercise price of $6.92 per share, were granted on January 9, 2026, and expire on January 8, 2031. The grant was reported as a direct holding.
According to the vesting terms, 8,750 of these stock options vest on the grant date, with the remaining options vesting in seven equal quarterly installments afterward. Following this award, Adelman beneficially owns 70,000 derivative securities in the form of these options.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock (Right to Buy) | 70,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. 8,750 of the stock options vest on the date of the grant, with the remainder vesting equally over seven quarterly installments thereafter.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Trio-Tech International (TRT) report in this Form 4?
What is the exercise price and term of Jason Adelman’s options at Trio-Tech International (TRT)?
How do Jason Adelman’s Trio-Tech International (TRT) stock options vest?
How many Trio-Tech International (TRT) derivative securities does Jason Adelman own after this transaction?
Is Jason Adelman a director or officer of Trio-Tech International (TRT)?
AI-generated analysis. How Rhea-AI works. Not financial advice.